Focus: Lee's Pharmaceutical is a publicly traded Chinese pharmaceutical company headquartered in Guangzhou specializing in small molecule therapeutics across oncology, cardiovascular, neurology, and nephrology indications.
Profile data last refreshed Yesterday · AI intelligence enriched 2mo ago
No open roles listed right now. Follow Lee's Pharmaceutical to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Marquee NDA-approved product at peak commercial stage, serving as the primary revenue driver and financial anchor for pipeline investment.
Help build intelligence for Lee's Pharmaceutical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Lee's Pharmaceutical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Lee's Pharmaceutical Holdings Limited received a purchase of 41,500 shares by its Managing Director, Li Yeni, at HK$1.06 per share. - 富途牛牛
Lee's Pharmaceutical Holdings Limited received a purchase of 41,500 shares by its Managing Director, Li Yeni, at HK$1.06 per share. 富途牛牛
Lee’s Pharmaceutical Receives Gates Foundation Funding for Synthetic Surfactant Project to Aid Premature Infants in Low- and Middle-Income Countries 1 - Minichart
Lee’s Pharmaceutical Receives Gates Foundation Funding for Synthetic Surfactant Project to Aid Premature Infants in Low- and Middle-Income Countries 1 Minichart
Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project - TradingView
Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project TradingView
Read This Before Considering Lee's Pharmaceutical Holdings Limited (HKG:950) For Its Upcoming HK$0.023 Dividend - simplywall.st
Read This Before Considering Lee's Pharmaceutical Holdings Limited (HKG:950) For Its Upcoming HK$0.023 Dividend simplywall.st
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moRecent peer-reviewed publications with author affiliations at this company
Phase I Clinical Study of a Multi-Kinase Inhibitor TG02 Capsule for the Treatment of Recurrent High-Grade Gliomas with Failed Temozolomide Treatment in Chinese Patients.
Efficacy and Safety of a Fixed-Dose Combination Gel with Adapalene 0.1% and Clindamycin 1% for the Treatment of Acne Vulgaris (CACTUS): A Randomized, Controlled, Assessor-Blind, Phase III Clinical Trial.
Showing 5 of 10 publications